By National Academy of Sciences

From the webpage: "At the request of the National Security Commission on Emerging Biotechnology, Strategic Report on Research and Development in Biotechnology for Defense Innovation provides an overview of the current landscape of artificial intelligence and machine learning (AI/ML)-enabled biotechnology, the opportunities it presents, and the challenges it poses. This report offers a strategic vision for connecting scientists and technologists to build on, leverage, and tailor advances at the intersection of AI/ML, automated experimentation, and biotechnology to drive innovation in defence-related biotechnologies. Strategic Report on Research and Development in Biotechnology for Defense Innovation recommends addressing long-standing challenges with limited research, development, prototyping, testing and evaluation, and eventual use of biotechnologies. Addressing these challenges will help to advance U.S. national security and defence by improving the performance of existing capabilities, enabling the creation of domestic supply chains of valuable products, reducing reliance on processes and chemicals that are harmful to the environment, and/or adding new capabilities not currently possible with established technologies." Contributors include the National Academies of Sciences, Engineering, and Medicine; Division on Earth and Life Studies; Board on Life Sciences; and Committee on Biotechnology Capabilities for National Security Needs-Leveraging Advances in Transdisciplinary Biotechnology.

NATIONAL ACADEMIES PRESS (U.S.) 2025. 67p.

By United States. Department Of Defense

From the document: "The Department of Defense (DoD) is at a pivotal moment in biodefense as it faces an unprecedented number of complex biological threats (biothreats). This inaugural DoD Biodefense Posture Review (BPR) initiates key reforms--built on the foundations of the 2022 National Defense Strategy (NDS), the October 2022 National Biodefense Strategy and Implementation Plan for Countering Biological Threats, Enhancing Pandemic Preparedness, and Achieving Global Health Security (NBS); and lessons learned from the coronavirus disease 2019 (COVID-19) pandemic response--to posture DoD to counter biothreats through 2035. Developments in biological technology (biotechnology) are driving an increase in the scope and diversity of biothreats that DoD could face in the next decade. Additionally, as the planet's climate continues to change and its population grows, emerging infectious diseases are expected to develop and spread more frequently and potentially threaten DoD's readiness to achieve and maintain its national defense goals. The COVID-19 pandemic response presented opportunities for DoD to both improve its overall preparedness and posture, as well as to reinforce and reimagine its role in support of the broader U.S. Government and our allies and partners."

Washington D.C. United States. Department of Defense. 2023. 56p.